| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2008 | US20080188439 Xenobiotic substance that is hydroxylated or can be hydroxylated, a glucuronidation donor of uridine diphosphoglucuronic acid; reducing the incidence and degree of liver toxicity caused by chemical compounds susceptible to conjugational inactivation in the liver |
| 08/07/2008 | US20080188438 Oligonucleotide molecule that interferes with the Fra-1/VEGF-D promoter or the Fra-1/c-Jun interaction to a subject suffering from a brain cancer |
| 08/07/2008 | US20080188437 Compositions and Methods for siRNA Inhibition of Angiogenesis |
| 08/07/2008 | US20080188435 Methods of dignosing or treating depression on basis of increased cerebrospinal fluid levels of neurotrodhin 3 |
| 08/07/2008 | US20080188434 Providing a DNA sample, detecting the amplification of a nucleic acid sequence in chromosomal region 8p22, amplification indicates that the patient has, or is susceptible of developing cancer; inhibition of FGF-20 activity inhibits the growth of cancer cells |
| 08/07/2008 | US20080188433 Methods of diagnosis of spinal muscular atrophy and treatments thereof |
| 08/07/2008 | US20080188432 Short nucleotide subsequences located within number 15; such as locked nucleic acids antisense oligonucleotides; biostability, cell permeability; anticancer agents |
| 08/07/2008 | US20080188430 RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA) |
| 08/07/2008 | US20080188429 Synthetic siRNA compounds and methods for the downregulation of gene expression |
| 08/07/2008 | US20080188428 Bioinformatically detectable group of novel hiv regulatory genes and uses thereof |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 08/07/2008 | US20080188424 Topical non-pharmaceutical cosmetic, personal and pet care products with chiral technology and methods of formulating and manufacturing the same |
| 08/07/2008 | US20080188423 Pi-3 kinase inhibitor prodrugs |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188415 Composition of matter containing harmonized hydroxyl modified fullerene substance |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187993 Coupling antisense angents to reverse TAT polypeptide to enhance uptake into activated macrophage and/or lymphocytes; prevention and treatment of human immunodeficiency viral infection |
| 08/07/2008 | US20080187978 Anti-inflammatory medicaments |
| 08/07/2008 | US20080187928 Using GW1516 (an activator of amp-activated protein kinase and stimulator of glucose uptake) to intensify peroxisome proliferator activator receptor activity and improve exercise endurance; control for detecting use of performance enhancing drugs |
| 08/07/2008 | US20080187622 Method for manufacturing alpha-glycosylisoquercitrin, intermediate product and by-product thereof |
| 08/07/2008 | US20080187605 Preventing pathological nerve cell suicide (neuroapoptosis) in immature nervous systems |
| 08/07/2008 | US20080187594 Dosage Form With Improved Release Of Cefuroximaxetil |
| 08/07/2008 | US20080187593 Administering sophorolipids; antiallergens, atopic diseases; skin disorders; antiinflammatory agents; autoimmune diseases; multiple sclerosis |
| 08/07/2008 | US20080187590 Containing entacapone; therapy for parkinson's disease |
| 08/07/2008 | US20080187589 Multi-modal delivery via transmucosal and gastro-intestinal absorption of antihistamines and symptom relief |
| 08/07/2008 | US20080187588 Containing phosphodiesterase inhibitor vardensfil; erectile dysfunction |
| 08/07/2008 | US20080187587 Multilayer capsules for sustained release ; therapy for sleep disorders |
| 08/07/2008 | US20080187586 Pharmaceutical Compositions for Glucocorticoid Replacement Therapy |
| 08/07/2008 | US20080187585 Side effect reduction of diuretic |
| 08/07/2008 | US20080187584 Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof |
| 08/07/2008 | US20080187582 Solid dosage of water sensitive drug; oral administering; prevention, therapy for diseases mediated by lymphocytes; protein kinase inhibitor |
| 08/07/2008 | US20080187581 Solid dosage form; active materials and solid on substrate |
| 08/07/2008 | US20080187580 Using 1,3-oxathiolane compound; against hepatitis B viral infections |
| 08/07/2008 | US20080187579 Extended-release dosage form |
| 08/07/2008 | US20080187578 Platinum Aggregates and Process for Producing the Same |
| 08/07/2008 | US20080187577 Immunogenic compositions comprising progastrin and uses thereof |
| 08/07/2008 | US20080187576 Osteoarthritis; rheumatic diseases; gene therapy; interleukin receptor antagonist peptide or polypeptide |
| 08/07/2008 | US20080187575 Pyrimidine Derivatives |
| 08/07/2008 | US20080187573 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component |
| 08/07/2008 | US20080187572 Administering compound which stabilizes cadherin |
| 08/07/2008 | US20080187570 Improve tissue response at site of implant; containing polynucleotide and cation |
| 08/07/2008 | US20080187563 Oxygen delivery compositon |
| 08/07/2008 | US20080187561 Enteric Coated Didanosine Compositions Having A Subcoat |
| 08/07/2008 | US20080187555 Stable oil in water emulsion containing deactivated immunogen such as Mycoplasma or circovirus with mineral and nonionic surfactant ; induce immunology response |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187544 Treating and evaluating inflammatory disorders |
| 08/07/2008 | US20080187542 Herpesvirus entry mediator (HVEM) specific immunoglobulin for use in treatment and prevention of transplant rejection, graft-versus-host and transplant autoimmune diseases |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy |
| 08/07/2008 | US20080187536 Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187530 Novel Agents and Use Thereof |
| 08/07/2008 | US20080187527 Novel endometriosis-associated gene |
| 08/07/2008 | US20080187526 Mixture comprising antioxidants for use in enhancing, preventing and treating hearing disorders |
| 08/07/2008 | US20080187523 Nucleotide sequences coding genetically engineered zinc finger protein for use in treatment and prevention of cell proliferative disorders |
| 08/07/2008 | US20080187516 Acyclic oximyl hepatitis c protease inhibitors |
| 08/07/2008 | US20080187513 Treatment of Solid Cancers |
| 08/07/2008 | US20080187512 Using activator which stimulates signal transducers and activators of transcription (STAT5) gene sequences as therapeutic tools in treatment of neuromuscular disorders |
| 08/07/2008 | US20080187511 Ointment for cancer treatment |
| 08/07/2008 | US20080187510 Methods for Improving Drug Disposition |
| 08/07/2008 | US20080187508 Treatment of Golmerular Basement Membrane Disease Involving Matrix Metalloproteinase-12 |
| 08/07/2008 | US20080187492 Determining whether a compound, an inhibitor of a glutamate receptor, reduces Fragile X syndrome, a tauopathy, Huntington's disease, neurofibromatosis 1, Parkinson's disease of an analogous disease in a Drosophila |
| 08/07/2008 | DE202007018474U1 Kirstallformen von 9-Hydroxy-Risperidon (Paliperidon) Kirstallformen of 9-hydroxy-risperidone (paliperidone) |
| 08/07/2008 | DE202007018473U1 9-Hydroxy-Risperidon (Paliperidon) 9-hydroxy-risperidone (paliperidone) |
| 08/07/2008 | DE102007061631A1 Verfahren zur Herstellung von Mycophenolat-Mofetil Process for the preparation of mycophenolate mofetil |
| 08/07/2008 | DE102007005045A1 New phenothiazine derivative for use in preparing medicine for blood sugar lowering and for treatment of diabetes, nicotine dependence, alcohol dependence, central nervous system disorders, schizophrenia, and Alzheimer's disease |
| 08/07/2008 | DE102007004781A1 Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels The use of guanidinoacetic acid (salts) for the preparation of a beneficial agent |
| 08/07/2008 | DE102007004732A1 Enrofloxacin-Hexahydrat Enrofloxacin hexahydrate |
| 08/07/2008 | DE102006060953A1 Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate |
| 08/07/2008 | DE102006053594B4 Verfahren zur Reinigung von Letrozol A process for purifying letrozole |
| 08/07/2008 | CA2824842A1 Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2680843A1 Pharmaceutical composition for treatment of diabetic complications |
| 08/07/2008 | CA2678391A1 Dosage regimen for comt inhibitors |
| 08/07/2008 | CA2677253A1 Formulations of lipophilic bioactive molecules |
| 08/07/2008 | CA2677214A1 Potentiation of stem cell homing and treatment of organ dysfunction or organ failure |
| 08/07/2008 | CA2677205A1 Topiramate plus naltrexone for the treatment of addictive disorders |
| 08/07/2008 | CA2677193A1 Tablet preparation without causing a tableting trouble |
| 08/07/2008 | CA2677170A1 Polymorphic forms of a macrocyclic inhibitor of hcv |
| 08/07/2008 | CA2677168A1 Pteridinone derivatives as pi3-kinases inhibitors |
| 08/07/2008 | CA2677167A1 Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris |
| 08/07/2008 | CA2677125A1 Drug substance preparations, pharmaceutical compositions and dosage forms |
| 08/07/2008 | CA2677096A1 Kinase inhibitors |
| 08/07/2008 | CA2677061A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 08/07/2008 | CA2677053A1 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 08/07/2008 | CA2677044A1 Novel .beta.-lactam antibiotics, methods for their production, and their use |
| 08/07/2008 | CA2676991A1 Methods and compositions for the treatment of pain |
| 08/07/2008 | CA2676986A1 Pharmaceutical composition comprising a campothecin derivative |
| 08/07/2008 | CA2676984A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | CA2676977A1 Use of chromium histidinate for treatment of cardiometabolic disorders |
| 08/07/2008 | CA2676822A1 2-5a analogs and their methods of use |
| 08/07/2008 | CA2676796A1 Composition for treatment of undifferentiated gastric cancer |
| 08/07/2008 | CA2676698A1 Enrofloxacin-hexahydrate |
| 08/07/2008 | CA2676665A1 Modulators of mitotic kinases |
| 08/07/2008 | CA2676658A1 Modulators of mitotic kinases |
| 08/07/2008 | CA2676553A1 Use of er.beta. selective ligands for treating acute lung injuries |
| 08/07/2008 | CA2676551A1 Compositions and methods of use of phorbol esters |
| 08/07/2008 | CA2676291A1 Substituted gamma lactams as therapeutic agents |
| 08/07/2008 | CA2676168A1 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors |